196 related articles for article (PubMed ID: 34420983)
21. Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
Hunjan MK; Roberts C; Karim S; Hague J
Clin Exp Dermatol; 2022 Jan; 47(1):188-190. PubMed ID: 34379821
[TBL] [Abstract][Full Text] [Related]
22. Circumscribed juvenile-onset pityriasis rubra pilaris with hypoparathyroidism and brachyonychia.
Rasi A; Soltani-Arabshahi R; Naraghi ZS
Cutis; 2006 Apr; 77(4):218-22. PubMed ID: 16706238
[TBL] [Abstract][Full Text] [Related]
23. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.
Sechi A; Pierobon E; Pezzolo E; Germi L; Trevisan G; Zardo D; Riva G; Mondino S; Naldi L
Clin Exp Dermatol; 2022 Feb; 47(2):437-440. PubMed ID: 34617317
[No Abstract] [Full Text] [Related]
24. A Rare Post-infectious Rash: Pityriasis Rubra Pilaris After COVID-19 Infection.
Duncan P; Flood D; Dietz C
Cureus; 2023 Aug; 15(8):e43810. PubMed ID: 37731438
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
Boyd AH; Polcari IC
Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
[TBL] [Abstract][Full Text] [Related]
26. A Review on Pityriasis Rubra Pilaris.
Wang D; Chong VC; Chong WS; Oon HH
Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927
[TBL] [Abstract][Full Text] [Related]
27. Circumscribed juvenile pityriasis rubra pilaris.
Arnold AW; Buechner SA
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):705-7. PubMed ID: 15482302
[TBL] [Abstract][Full Text] [Related]
28. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
Camela E; Miano C; Di Caterino P; Lo Presti M; De Fata Salvatores G; Fabbrocini G; Megna M
Dermatol Ther; 2020 Nov; 33(6):e14223. PubMed ID: 32820849
[TBL] [Abstract][Full Text] [Related]
29. Pityriasis rubra pilaris with acantholysis.
Howe K; Foresman P; Griffin T; Johnson W
J Cutan Pathol; 1996 Jun; 23(3):270-4. PubMed ID: 8793664
[TBL] [Abstract][Full Text] [Related]
30. Recalcitrant psoriasiform dermatosis of the face: Is it related to pityriasis rubra pilaris?
Gan EY; Ng SK; Goh CL; Lee SSJ
J Cutan Pathol; 2018 Jul; 45(7):491-497. PubMed ID: 29604103
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept.
Guedes R; Leite L
Dermatol Ther; 2011; 24(2):285-6. PubMed ID: 21410618
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic pityriasis rubra pilaris: case report and literature review.
Bar-Ilan E; Gat A; Sprecher E; Zeeli T
Clin Exp Dermatol; 2017 Jan; 42(1):54-57. PubMed ID: 27896859
[TBL] [Abstract][Full Text] [Related]
33. Pityriasis rubra pilaris in association with laryngeal carcinoma.
Batinac T; Kujundzić M; Peternel S; Cabrijan L; Troselj-Vukić B; Petranović D
Clin Exp Dermatol; 2009 Dec; 34(8):e917-9. PubMed ID: 20055867
[TBL] [Abstract][Full Text] [Related]
34. A case of pityriasis rubra pilaris associated with membranous nephropathy.
Lin CY; Maurice PD; Cross NB
Australas J Dermatol; 2013 Feb; 54(1):e1-3. PubMed ID: 23373888
[TBL] [Abstract][Full Text] [Related]
35. Pityriasis Rubra Pilaris in a 3-Year-Old Male.
Stacey SK; Novek SJ; Maddox CL
Mil Med; 2016 Mar; 181(3):e298-301. PubMed ID: 26926758
[TBL] [Abstract][Full Text] [Related]
36. Drug-related pityriasis rubra pilaris with acantholysis.
Gajinov ZT; Matić MB; Duran VD; Vucković N; Prcić ST; Vujanović LM
Vojnosanit Pregl; 2013 Sep; 70(9):871-3. PubMed ID: 24266317
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic pityriasis rubra pilaris in association with prostate carcinoma: A case report and literature review.
Fekete GL; Boda D; Căruntu C; Fekete L
Exp Ther Med; 2019 Dec; 18(6):5052-5055. PubMed ID: 31798725
[TBL] [Abstract][Full Text] [Related]
38. Early Presentation of Pityriasis Rubra Pilaris Mimicking Tinea Corporis: Diagnostic Challenges of a Rare Skin Condition.
Abang Hashim DH; Ismail IA; Tawil Z; Abd Halim H
Am J Case Rep; 2022 Aug; 23():e936906. PubMed ID: 35988013
[TBL] [Abstract][Full Text] [Related]
39. Response to "An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris".
Mungmunpuntipantip R; Wiwanitkit V
Int J Risk Saf Med; 2022; 33(3):333. PubMed ID: 35466959
[No Abstract] [Full Text] [Related]
40. Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin.
Criado PR; Ianhez M; Rocha PS; Miot HA
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e508-e510. PubMed ID: 35278239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
